Agilisium, a Life Sciences innovation and transformation company, will be shifting its Asia headquarters from Chennai to Hyderabad.
The shift to Hyderabad is aimed at taping into Hyderabad’s strong pharmaceutical and biotechnology ecosystem, the company said on Tuesday.
Hyderabad offers access to specialised talent in Life Sciences, technology and AI. “Telangana’s growing focus on Life Sciences innovation, supported by its dedicated leadership and the BioAsia platform, further strengthens the city’s appeal,” it said.
“The move will help Agilisium strengthen its innovation capabilities and develop specialised solutions for global Life Sciences companies,” it added.
It also supports the company’s long-term goal of reaching $500 million in revenue and expanding its workforce to approximately 5,000 professionals over the next five to seven years.
Chennai and Pune will continue to remain part of its core operating footprint, according to the company.
Published on October 27, 2026
